focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Any serious investor will appreciate the work being done at the moment takes time and patience will hopefully be reward handsomely. Day traders and the like are intrinsically impatient and if the market moves against them they start whingeing and ****ging off MMs etc. Chill and enjoy the ride.
Recent placings = 350 million new shares @2p - or 350 x 1milion share dumpings. They're obviously not going to dump huge numbers to collapse the share price when the volume isn't there to support it so I can see us here until they're cleared or derisked to a level they're comfortable with. Watch out for tree shakes alonhg the way though!
Who knows, the YA conversion and the 2 placements within a week killed off the huge volumes we had earlier this month so it'll take longer to churn through them. Hopefully YA are out because they could sell below 2p at a profit but the recent placees can't.
When the 200 bopd news was released, I wasn't doing backdrops due to Mr vonk banding 400 bopd figures around last summer for lydsey alone.... I hope we do strike it big and if we hit a pound a share I'll have got my money back, good luck to all.
Like I said, I've been here since the start doing battle with the likes of BDI, Caristom et al. I wish I was a paid deramper. I wouldn't feel like such an absolute mug then! Can't believe I defended this toilet in the past, live and learn.
I've been here since the IPO, it's been emotional to say the least! One thing I've learnt is that the RNS releases are generally vague and you need to pay attention to what's not being said. I wish I had something positive to say about the company but everything has been handled terribly so far. Maybe with a punt and check back in the winter to see if anything has improved but I'm not holding my breath any more.
Is not flow testing shortly - Angus applied for operatotship of the license block, this hasn't been granted by the looks of it, neither has flow test consent from the OGA. This company is an absolute shambles, so glad I'm only left with a small speculative holding. It was all looking so promising too, hey ho.
Is there anything stopping them taking the product to market with the "reduced GI irritation" claim and then upgrading this claim once the relevant studies have been carried out and got FDA sign off?
Worth mentioning Woodford ploughed in £10m @ 10p per share during a placing so he obviously sees this much higher longer term. Hi everyone by the way, I've recently joined the party so roll on FDA!